CLINICAL_TRIALS
trial_result
· 2025-09-19
Clinical Trial Update: Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance [NA]
Summary
A recruiting clinical trial is evaluating whether ursodeoxycholic acid can mitigate statin-induced impaired glucose tolerance in patients with hyperlipidemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Hyperlipidemia, Ursodeoxycholic Acid | NA | Status: RECRUITING